54 related articles for article (PubMed ID: 8605773)
1. Developments in echo-enhancing agents.
Schlief R
Clin Radiol; 1996 Feb; 51 Suppl 1():5-7. PubMed ID: 8605773
[No Abstract] [Full Text] [Related]
2. EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids.
Correas JM; Quay SD
Clin Radiol; 1996 Feb; 51 Suppl 1():11-4. PubMed ID: 8605764
[No Abstract] [Full Text] [Related]
3. Ultrasound contrast. Oral and i.v. agents amplify the image.
Barr RG
Diagn Imaging (San Franc); 1999 Mar; 21(3):56-61. PubMed ID: 10351114
[No Abstract] [Full Text] [Related]
4. Sonographic evaluation of intervillous flow in early pregnancy: use of echo-enhancement agents.
Simpson NA; Nimrod C; De Vermette R; Leblanc C; Fournier J
Ultrasound Obstet Gynecol; 1998 Mar; 11(3):204-8. PubMed ID: 9589145
[TBL] [Abstract][Full Text] [Related]
5. Albunex and beyond.
Ostensen J
Clin Radiol; 1996 Feb; 51 Suppl 1():8-10. PubMed ID: 8605776
[No Abstract] [Full Text] [Related]
6. [Ultrasonographic contrast media].
Drudi F
Radiol Med; 2004 Apr; 107(4 Suppl 1):36-7. PubMed ID: 15323321
[No Abstract] [Full Text] [Related]
7. [The present-day of ultrasonographic techniques].
Suramo I; Päivänsalo M
Duodecim; 1999; 115(19):2063-70. PubMed ID: 11941800
[No Abstract] [Full Text] [Related]
8. Future prospects for echo-enhancing agents.
Fritzsch T; Schlief R
Clin Radiol; 1996 Feb; 51 Suppl 1():56-8. PubMed ID: 8605775
[No Abstract] [Full Text] [Related]
9. Albunex--a new ultrasound contrast agent. Effects on hemodynamics, contrast, and biodistribution in different species.
Walday P; Ostensen J; Tolleshaug H; Holtz E
Invest Radiol; 1994 Jun; 29 Suppl 2():S142-4. PubMed ID: 7928211
[No Abstract] [Full Text] [Related]
10. Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology.
Burns PN
J Neuroimaging; 1997 Apr; 7 Suppl 1():S2-14. PubMed ID: 9128460
[TBL] [Abstract][Full Text] [Related]
11. Reliability of semiquantitative ultrasonic perfusion imaging of the brain.
Eyding J; Wilkening W; Reckhardt M; Meves S; Postert T
J Neuroimaging; 2004 Apr; 14(2):143-9. PubMed ID: 15095560
[TBL] [Abstract][Full Text] [Related]
12. Contrast agents in ultrasound.
Blomley M; Cosgrove D
Br J Hosp Med; 1996 Jan 17-Feb 6; 55(1-2):6-7; discussion 7-8. PubMed ID: 8646397
[No Abstract] [Full Text] [Related]
13. Ultrasound contrast agents in liver imaging.
Leen E; McArdle CS
Clin Radiol; 1996 Feb; 51 Suppl 1():35-9. PubMed ID: 8605770
[No Abstract] [Full Text] [Related]
14. Evaluation of changes in skeletal muscle blood flow in the dog with contrast ultrasonography revisited: has the technique been useful, and where are we headed now?
Lohman RF; Schechter LS; Zachary LS; Aronson S
Plast Reconstr Surg; 2003 Apr; 111(4):1477-80. PubMed ID: 12618609
[No Abstract] [Full Text] [Related]
15. Advantages of subharmonic over second harmonic backscatter for contrast-to-tissue echo enhancement.
Shankar PM; Dala Krishna P; Newhouse VL
Ultrasound Med Biol; 1998 Mar; 24(3):395-9. PubMed ID: 9587994
[TBL] [Abstract][Full Text] [Related]
16. Blood-pool echo enhancement after intravenous injection of galactose-based microbubbles: results from European phase III clinical trials in Doppler sonography.
Schlief R; Schürmann R; Niendorf HP
Acad Radiol; 1996 Aug; 3 Suppl 2():S466-7. PubMed ID: 8796631
[No Abstract] [Full Text] [Related]
17. Ultrasound contrast enhancement of tumours.
Cosgrove D
Clin Radiol; 1996 Feb; 51 Suppl 1():44-9. PubMed ID: 8605772
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of SHU 508A: enhancement of arterial Doppler color flow imaging.
Goldstein HA; Wiggins J; Jacob G
Acad Radiol; 1996 Aug; 3 Suppl 2():S468-70. PubMed ID: 8796632
[No Abstract] [Full Text] [Related]
19. Microbubble echo-enhancers: a new direction for ultrasound?
Blomley M; Cosgrove D
Lancet; 1997 Jun; 349(9069):1855-6. PubMed ID: 9217754
[No Abstract] [Full Text] [Related]
20. Ultrasound contrast agents.
Goldberg BB
Clin Diagn Ultrasound; 1993; 28():35-45. PubMed ID: 8476645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
